AMSL.XC
Advanced Medical Solutions Group plc
Cboe UKGBpEQUITY
Healthcare
DELAYED
Last price
281.50
▲ 0.25 (0.09%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
281.50
Prev close
281.25
Day high
281.50
Day low
281.50
Volume
3.87K
Market cap
$609.18M
P/E (TTM)
5,630.00
52W range
187.20 – 283.00
Day trading desk
Gap from prior close
+0.09%
Prior close 281.25
VWAP
281.50
0.00% from price
Relative volume
0.06×
Quiet session
Session range
—
281.50 – 281.50
Position in range
—
—
ATR (14D)
0.77
0.27% of price
Prior day high
281.50
PDH
Prior day low
280.50
PDL
Bid / ask spread
—
Quote not published
Session volume
7.54K
Avg 134.26K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.18%
+1.5%
1M
+0.45%
-3.3%
3M
+31.24%
+28.1%
6M
+32.47%
+21.4%
YTD
+28.39%
+16.1%
1Y
+35.17%
+15.2%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AMSL.XC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
16.70M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | Barclays, Plc. |
INCREASE | 26.96K | $101.16K | Direct |
| Aug 19, 26 | Societe Generale Asset Management (France) |
BUY | 402.92K | $1.51M | Direct |
| Aug 19, 26 | Octopus Investments Ltd |
SELL | 190.91K | $716.30K | Direct |
| Aug 19, 26 | Hargreave Hale Ltd |
SELL | 6.64K | $24.93K | Direct |
| Aug 18, 26 | Hargreave Hale Ltd |
SELL | 1.43K | $5.35K | Direct |
| Aug 18, 26 | Jefferies International, Ltd. |
BUY | 57.35K | $215.16K | Direct |
| Aug 18, 26 | Jefferies International, Ltd. |
SELL | 102.35K | $384.00K | Direct |
| Aug 18, 26 | Octopus Investments Ltd |
SELL | 17.46K | $65.51K | Direct |
| Aug 18, 26 | Barclays, Plc. |
BUY | 117.74K | $441.77K | Direct |
| Aug 18, 26 | Barclays, Plc. |
SELL | 109.41K | $410.49K | Direct |
| Aug 17, 26 | Barclays, Plc. |
BUY | 59.56K | $223.47K | Direct |
| Aug 17, 26 | Barclays, Plc. |
SELL | 53.65K | $201.31K | Direct |
| Aug 17, 26 | Octopus Investments Ltd |
DECREASE | 28.11K | $105.48K | Direct |
| Aug 17, 26 | PSquared Asset Management AG |
SELL | 659.46K | $2.47M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Alpine Associates |
— | 7.84M | Bought |
Barclays, Plc. |
— | 6.74M | Increase |
Compagnie Odier SCA |
— | 8.46M | Annual Return |
Hargreave Hale Ltd |
— | 9.47M | Sold |
J.P. Morgan Securities PLC |
— | 8.62M | Holding |
Morgan Stanley & Co International Ltd |
— | 11.34M | Decrease |
Octopus Investments Ltd |
— | 16.67M | Sold |
Sand Grove Capital Management LLP |
— | 6.32M | Sold |
Societe Generale Asset Management (France) |
— | 7.51M | Bought |
Trium Capital LLP |
— | 5.71M | Bought |
Fundamentals
Market cap$609.18M
Enterprise value$671.75M
Revenue (TTM)$228.94M
Gross profit$122.14M
EBITDA$37.04M
Net income$9.95M
EPS (TTM)$0.05
Free cash flow$11.26M
Total cash$18.02M
Total debt$81.52M
Book value / share$1.20
Shares outstanding216.40M
Float189.85M
Short % of float—
Dividend yield1.02%
Beta (5Y)0.70
Valuation & profitability ratios
Trailing P/E5,630.00
Forward P/E—
PEG ratio—
Price / sales—
Price / book234.39
EV / revenue2.93
EV / EBITDA18.13
Gross margin53.35%
Operating margin10.10%
Profit margin4.35%
Return on equity4.03%
Return on assets3.62%
Debt / equity31.34
Current ratio2.79
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $228.94M | $177.52M | $126.21M | $124.33M | +29.0% |
| Operating revenue | $228.94M | $177.52M | $126.21M | $124.33M | +29.0% |
| Cost of revenue | $106.80M | $84.90M | $56.07M | $50.91M | +25.8% |
| Gross profit | $122.14M | $92.62M | $70.14M | $73.42M | +31.9% |
| Selling, general & admin | $94.34M | $71.38M | $52.19M | $49.00M | +32.2% |
| Total operating expense | $93.67M | $70.47M | $51.26M | $48.53M | +32.9% |
| Operating income | $28.47M | $22.14M | $18.88M | $24.89M | +28.6% |
| Net interest income | -$4.88M | -$2.26M | $2.09M | $181.00K | -115.5% |
| Pre-tax income | $17.78M | $9.82M | $21.16M | $25.91M | +81.0% |
| Tax provision | $7.69M | $2.68M | $5.27M | $5.50M | +186.8% |
| Net income | $9.95M | $7.09M | $15.89M | $20.41M | +40.3% |
| Net income to common | $9.95M | $7.09M | $15.89M | $20.41M | +40.3% |
| Basic EPS | 0.05 | 0.03 | 0.07 | 0.09 | +39.6% |
| Diluted EPS | 0.05 | 0.03 | 0.07 | 0.09 | +39.1% |
| EBIT | $22.59M | $13.22M | $21.54M | $26.28M | +70.8% |
| EBITDA | $43.98M | $29.53M | $32.33M | $35.12M | +49.0% |
| Basic shares | 215.54M | 214.34M | 215.90M | 216.51M | +0.6% |
| Diluted shares | 220.01M | 218.30M | 219.29M | 219.48M | +0.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $18.02M | $17.04M | $60.16M | $82.26M | +5.7% |
| Cash & short-term investments | $18.02M | $17.04M | $60.16M | $82.26M | +5.7% |
| Accounts receivable | $38.46M | $45.91M | $20.91M | $17.71M | -16.2% |
| Inventory | $70.05M | $55.26M | $36.05M | $27.91M | +26.8% |
| Total current assets | $139.37M | $126.28M | $122.32M | $131.91M | +10.4% |
| Property, plant & equipment | $48.75M | $45.87M | $29.60M | $29.02M | +6.3% |
| Goodwill & intangibles | $205.42M | $214.30M | $136.30M | $119.23M | -4.1% |
| Total assets | $394.77M | $388.50M | $289.17M | $281.09M | +1.6% |
| Total current liabilities | $49.95M | $44.33M | $21.58M | $22.68M | +12.7% |
| Current debt | $11.37M | $5.42M | $0 | — | +109.7% |
| Long-term debt | $57.10M | $67.43M | $0 | — | -15.3% |
| Total debt | $81.52M | $86.56M | $9.14M | $9.75M | -5.8% |
| Total liabilities | $134.67M | $146.98M | $44.97M | $44.47M | -8.4% |
| Retained earnings | $184.64M | $180.47M | $178.53M | $167.42M | +2.3% |
| Shareholder equity | $258.79M | $240.78M | $244.20M | $236.62M | +7.5% |
| Working capital | $89.42M | $81.95M | $100.74M | $109.23M | +9.1% |
| Net tangible assets | $53.37M | $26.48M | $107.90M | $117.39M | +101.5% |
| Shares issued | 219.60M | 217.86M | 217.33M | 216.93M | +0.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $22.66M | $11.22M | $18.88M | $24.89M | — | +102.0% |
| Depreciation & amortisation | $21.40M | $16.30M | $10.79M | $8.84M | — | +31.3% |
| Stock-based compensation | $4.14M | $3.09M | $2.92M | $2.44M | — | +34.2% |
| Change in working capital | -$10.28M | -$6.07M | -$15.83M | -$5.97M | — | -69.4% |
| Operating cash flow | $32.59M | $19.49M | $12.35M | $26.88M | — | +67.2% |
| Capital expenditure | -$12.60M | -$8.74M | -$9.85M | -$9.96M | — | -44.1% |
| Investing cash flow | -$13.33M | -$67.15M | -$20.27M | -$11.88M | — | +80.1% |
| Share buybacks | — | $0 | -$6.71M | -$392.00K | -$366.00K | — |
| Dividends paid | -$5.79M | -$5.20M | -$4.78M | -$4.34M | — | -11.3% |
| Financing cash flow | -$18.97M | $5.48M | -$13.62M | -$6.32M | — | -446.3% |
| Free cash flow | $19.99M | $10.74M | $2.50M | $16.91M | — | +86.0% |
| End cash position | $18.02M | $17.04M | $60.16M | $82.26M | — | +5.7% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $18.02M | $19.34M | $17.04M | -6.8% |
| Cash & short-term investments | $18.02M | $19.34M | $17.04M | -6.8% |
| Accounts receivable | $38.46M | $50.09M | $45.91M | -23.2% |
| Inventory | $70.05M | $62.02M | $55.26M | +12.9% |
| Total current assets | $139.37M | $134.32M | $126.28M | +3.8% |
| Property, plant & equipment | $48.75M | $46.57M | $45.87M | +4.7% |
| Goodwill & intangibles | $205.42M | $213.28M | $214.30M | -3.7% |
| Total assets | $394.77M | $397.44M | $388.50M | -0.7% |
| Total current liabilities | $49.95M | $46.72M | $44.33M | +6.9% |
| Current debt | $11.37M | $9.47M | $5.42M | +20.1% |
| Long-term debt | $57.10M | $59.96M | $67.43M | -4.8% |
| Total debt | $81.52M | $82.38M | $86.56M | -1.0% |
| Total liabilities | $134.67M | $140.50M | $146.98M | -4.2% |
| Retained earnings | $184.64M | $186.63M | $180.47M | -1.1% |
| Shareholder equity | $258.79M | $256.24M | $240.78M | +1.0% |
| Working capital | $89.42M | $87.60M | $81.95M | +2.1% |
| Net tangible assets | $53.37M | $42.96M | $26.48M | +24.2% |
| Shares issued | 219.60M | 219.24M | 217.86M | +0.2% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $246.07M | +7.5% |
| Next year | — | — | $264.08M | +7.3% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders7.75%
Held by institutions77.05%
Institutions holding97
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
281.20
+0.11% from price
SMA 20
280.81
+0.24% from price
SMA 50
272.18
+3.43% from price
SMA 100
249.99
+12.60% from price
SMA 200
231.07
+21.82% from price
EMA 12
281.03
+0.17% from price
EMA 26
278.65
+1.02% from price
EMA 50
270.26
+4.16% from price
RSI (14)
69.1
Neutral
MACD (12,26,9)
2.38
Hist -0.85
ATR (14)
0.77
0.27% of price
Realised vol 30D
2.5%
Annualised
Bollinger upper
281.81
20, 2σ
Bollinger lower
279.81
20, 2σ
50 / 200 cross
Golden
272.18 vs 231.07
Trend bias
Above 200
+21.82%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.12
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
2.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-22.5%
Peak to trough
Max drawdown 5Y
-56.8%
Peak to trough
ATR 14
0.77
0.27% of price
Beta (reported)
0.70
5Y monthly, from filing
Dividends & splits
Forward rate$0.03 / yr
Forward yield1.02%
5-year avg yield—
Payout ratio18.81%
Ex-dividend dateMay 28, 2026
Next pay date—
Last split—
Split date—
Headlines
Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?
Motley Fool · 11m ago
TransUnion (TRU) Stock Looks Reasonable Despite A 27% Five Year Decline
Simply Wall St. · 17m ago
Is Verizon Communications (VZ) Cheap Following Its Planned $1.25b Note Redemption?
Simply Wall St. · 17m ago
Billionaire Druckenmiller makes cancer stock his #1 buy for a reason
TheStreet · 17m ago
147 Laps Around the Mall: Washington Hosts Freedom 250 Street Race
The Wall Street Journal · 23m ago
After Buying Circle Through a 42% Drop, Cathie Wood Says Analysts Cannot Fathom It
BeInCrypto · 24m ago
BC-Nikkei 225 Futures
Associated Press · 24m ago
Hugging Face exploring sale valuing it at $13 billion, Business Insider says
Reuters · 24m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.